Neoadjuvant therapy for esophageal cancer - What can we accept?

Hepato-Gastroenterology

Volumn 53, Issue 71, 2006, Pages 720-722

  Král, Vladimír ^a   Neoral, Cestmír ^a   Aujesky, René ^a   Havlík, Roman ^a   Klein, Jirí ^a   Hajdúch, Marian ^a   Svébisová, Hana ^a   Benes, Petr ^a   Vrba, Radek ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Esophageal cancer; Neoadjuvant therapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FISTULA; HUMAN; MAJOR CLINICAL STUDY; PATIENT CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES;

EID: 33750598007     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Medical Research Council Oesophageal Cancer Working Party: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial Lancet 2002; 359:1727-1733.
2. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 337:462-467.
3. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery ibr localized squamous cell carcinoma ot the esophagus. Cancer 1994; 73:1779-1784.
4. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al: Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16:1104-1110.
5. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994; 41:391-393.
6. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al: Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997; 337:161-167.
7. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19:305-313.
8. Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M: Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy. Radiology 1999; 213:67-72.
9. DeCamp MM Jr, Swanson SJ, Jaklitsch MT: Esophagectomy after induction chemoradiation. Chest 1999; 116(Suppl):466S-469S.
10. Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW: Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001; 181:440-444.
11. Meneu-Diaz JC: The role of multimodality therapy for resectable esophageal cancer. Am J Surg 2000; 179:508-513.
12. Smithers BM, Devitt P, Jamison GG, Bessell J, Gotley D, Gill PG, et al: A combined modality approach to the management of oesophageal cancer. Eur J Surg Oncol 1997; 23:219-223.
13. Brucher BL, Weber W, Bauer M, et al: Neoadjuvant therapy of oesophageal squamous cell carcinoma: response by positron emission tomography. Ann Surg 2001; 2333:300-309.
14. Geh JI, Crellin AM, Glynne-Jones RG: Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001; 88:338-356.
15. Makary MA, Kiernan PD, Sheridan MJ, Tonnesen G, Hetrick V, Vaughan B, Gralling P, Elster E: Multimodality treatment for oesophageal cancer: the role of surgery and neoadjuvant therapy. Am Surg 2003; 69:693-700.